CYTEK BIOSCIENCES INC (CTKB) Stock Balance Sheet
NASDAQ:CTKB • US23285D1090
Current stock price
4.3 USD
-0.02 (-0.46%)
At close:
4.3 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 28.98M | 32.25M | 22.41M | 123.40M | 18.90M | |||
| Cash Equivalents | 61.87M | 66.47M | 144.89M | 173.20M | 345.70M | |||
| Marketable Securities | 170.68M | 179.15M | 95.11M | 44.50M | N/A | |||
| Receivables | 67.92M | 60.59M | 56.12M | 50.90M | 29.60M | |||
| Inventories | 48.43M | 43.89M | 60.88M | 48.20M | 32.20M | |||
| Other Current Assets | 14.12M | 14.10M | 12.65M | 13.80M | 5.30M | |||
| Total Current Assets | 392.00M | 396.45M | 392.06M | 454.00M | 431.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 29.32M | 28.13M | 29.26M | 27.60M | 5.90M | |||
| Goodwill | 16.70M | 16.66M | 16.18M | 10.10M | 10.10M | |||
| Intangibles | 16.82M | 20.13M | 23.08M | 4.30M | 4.70M | |||
| Other Non-Current Assets | 6.70M | 38.13M | 33.87M | 23.40M | 10.80M | |||
| Total Non-Current Assets | 69.55M | 103.05M | 102.40M | 65.50M | 31.60M | |||
| TOTAL ASSETS | 461.54M | 499.50M | 494.46M | 519.50M | 463.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 6.30M | 4.66M | 565.00K | 600.00K | N/A | |||
| Accrued Expenses | 29.51M | 27.24M | 24.24M | 25.50M | 16.70M | |||
| Accounts Payable | 6.41M | 5.53M | 3.03M | 4.80M | 3.00M | |||
| Other Current Liabilities | 35.59M | 30.23M | 28.39M | 18.20M | 13.50M | |||
| Total Current Liabilities | 77.80M | 67.66M | 56.23M | 49.00M | 33.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 525.00K | 1.05M | 1.65M | 2.30M | 0.00 | |||
| Other Non-Current Liabilities | 41.47M | 35.05M | 43.52M | 42.60M | 24.70M | |||
| Total Non-Current Liabilities | 42.00M | 36.10M | 45.17M | 45.20M | 25.10M | |||
| TOTAL LIABILITIES | 119.80M | 103.76M | 101.39M | 94.20M | 58.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -101.74M | -35.20M | -29.18M | -17.00M | -19.60M | |||
| Additional Paid In Capital | 441.11M | 430.79M | 423.39M | 442.90M | 423.60M | |||
| Minority Interest | N/A | N/A | 0.00 | 300.00K | 300.00K | |||
| Common Shares | 129.00K | 129.00K | 131.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 2.24M | 16.00K | -1.27M | -700.00K | 900.00K | |||
| Shares Outstanding | 128.55M | 129.21M | 130.71M | 135.40M | 133.70M | |||
| Tangible Book Value per Share | 2.40 | 2.78 | 2.71 | 3.03 | 2.92 | |||
| Total Shareholders' Equity | 341.74M | 395.74M | 393.06M | 425.30M | 405.00M | |||
| TOTAL LIABILITIES AND EQUITY | 461.54M | 499.50M | 494.46M | 519.50M | 463.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.01 | N/A | |||
| Current Ratio | 5.04 | 5.86 | 6.97 | 9.27 | 13.00 | |||
| Return On Assets (ROA) | -14.42% | -1.21% | -2.46% | 0.50% | N/A | |||
| Return On Equity (ROE) | -19.47% | -1.52% | -3.09% | 0.61% | N/A | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | 1.73% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | 8.80% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | 10.67% | |||
All data in USD , ROIC based on taxRate of 0.21